Compare · ASGN vs ASTH
ASGN vs ASTH
Side-by-side comparison of ASGN Incorporated (ASGN) and Astrana Health Inc. (ASTH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ASGN and ASTH operate in Professional Services (Consumer Discretionary), so they compete in similar markets.
- ASGN is the larger of the two at $5.83B, about 3.1x ASTH ($1.90B).
- Over the past year, ASGN is down 61.7% and ASTH is up 9.6% - ASTH leads by 71.3 points.
- ASGN has been more active in the news (23 items in the past 4 weeks vs 8 for ASTH).
- ASGN has more recent analyst coverage (15 ratings vs 6 for ASTH).
- Company
- ASGN Incorporated
- Astrana Health Inc.
- Price
- $19.39-52.08%
- $34.42+0.66%
- Market cap
- $5.83B
- $1.90B
- 1M return
- -48.94%
- +40.43%
- 1Y return
- -61.72%
- +9.62%
- Industry
- Professional Services
- Professional Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 1992
- News (4w)
- 23
- 8
- Recent ratings
- 15
- 6
ASGN Incorporated
ASGN Incorporated provides professional staffing and IT solutions in the technology, digital, creative, engineering and life sciences fields across commercial and government sectors in the United States and internationally. The company operates through three segments: Apex, Oxford, and ECS. The Apex segment offers technology, digital, creative, scientific, engineering staffing, and consulting services to Fortune 1000 and mid-market commercial clients. The Oxford segment provides hard-to-find technology, digital, engineering, and life sciences staffing and consulting services in various skill and geographic markets. The ECS Segment delivers advanced solutions in cloud, cyber security, artificial intelligence, machine learning, application and IT modernization, and science and engineering. The company was formerly known as On Assignment, Inc. and changed its name to ASGN Incorporated in April 2018. ASGN Incorporated was incorporated in 1985 and is headquartered in Glen Allen, Virginia.
Latest ASGN
- SEC Form 10-Q filed by ASGN Incorporated
- Director Dyer Joseph Wendell bought $24,992 worth of shares (1,112 units at $22.47), increasing direct ownership by 6% to 19,953 units (SEC Form 4)
- Chief Accounting Officer Cunningham Rose bought $25,054 worth of shares (1,125 units at $22.27), increasing direct ownership by 8% to 15,587 units (SEC Form 4)
- President Iyer Sadasivam bought $25,164 worth of shares (1,110 units at $22.67), increasing direct ownership by 2% to 61,905 units (SEC Form 4)
- Director Obermaier Patricia L bought $51,512 worth of shares (2,500 units at $20.61), increasing direct ownership by 35% to 9,548 units (SEC Form 4)
- EVP, Chief Financial Officer Perry Marie bought $100,018 worth of shares (5,350 units at $18.70), increasing direct ownership by 10% to 58,328 units (SEC Form 4)
- Director Lindstrom Carol bought $4,977 worth of shares (247 units at $20.15), increasing direct ownership by 2% to 11,558 units (SEC Form 4)
- Director Callaghan Brian J. bought $103,800 worth of shares (5,121 units at $20.27) (SEC Form 4)
- Chief Executive Officer Hanson Theodore S. bought $999,786 worth of shares (51,965 units at $19.24) (SEC Form 4)
- Director Frantz Mark A. bought $71,896 worth of shares (3,800 units at $18.92), increasing direct ownership by 21% to 22,001 units (SEC Form 4)
Latest ASTH
- Astrana Health, Inc. Schedules 2026 First Quarter Financial Results Release and Conference Call
- SEC Form DEFA14A filed by Astrana Health Inc.
- SEC Form DEF 14A filed by Astrana Health Inc.
- SEC Form 4 filed by Basho Chandan
- Astrana Health, Inc. to Participate in Upcoming Investor Conferences
- SEC Form 4 filed by Lam Thomas S.
- SEC Form 4 filed by Sim Kenneth T.
- SEC Form 4 filed by Sim Brandon
- SEC Form 4 filed by Kumar Dinesh M.
- SEC Form 4 filed by Basho Chandan